LEEEF
+0.0 · +0.00%
USD · OTCQB

Leef Brands Inc.(LEEEF) Stock Analysis | Healthcare

USD --+0.00%
Reward53Moderate
Risk50Moderate
75%Data
Thin -42% profit margin · Revenue growing 24% YoY
Profitless Growth
Market Cap:25.64M
ⓘ
Reward Rating
53
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
ⓘ
Risk Rating
50
Moderate
Risk Assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on LEEEF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Leef Brands Inc.?

operates as a cannabis branded products manufacturer in the United States.

AI Brief Pro

The brief on Leef Brands Inc.

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Leef Brands Inc.?

operates as a cannabis branded products manufacturer in the United States. The company operates in two segments: Wholesale Concentrates and Retail. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 25.64M.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (53)

Similar stocks to compare

A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Beta0.346
Insider Activity
12M windowNo data
No insider activity data available for this ticker.